A2 Review article in a scientific journal

The role of Interleukin-32 in autoimmunity




List of Authors: Albuquerque R, Komsi E, Starskaia I, Ullah U, Lahesmaa R

Publisher: WILEY

Publication year: 2021

Journal: Scandinavian Journal of Immunology

Journal name in source: SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Journal acronym: SCAND J IMMUNOL

Volume number: 93

Issue number: 2

Number of pages: 9

ISSN: 0300-9475

eISSN: 1365-3083

DOI: http://dx.doi.org/10.1111/sji.13012

URL: https://onlinelibrary.wiley.com/doi/10.1111/sji.13012


Abstract
Interleukin-32 (IL-32) is a pro-inflammatory cytokine that induces other cytokines involved in inflammation, including tumour necrosis factor (TNF)-alpha, IL-6 and IL-1 beta. Recent evidence suggests that IL-32 has a crucial role in host defence against pathogens, as well as in the pathogenesis of chronic inflammation. Abnormal IL-32 expression has been linked to several autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel diseases, and a recent study suggested the importance of IL-32 in the pathogenesis of type 1 diabetes. However, despite accumulating evidence, many molecular characteristics of this cytokine, including the secretory route and the receptor for IL-32, remain largely unknown. In addition, the IL-32 gene is found in higher mammals but not in rodents. In this review, we outline the current knowledge of IL-32 biological functions, properties, and its role in autoimmune diseases. We particularly highlight the role of IL-32 in rheumatoid arthritis and type 1 diabetes.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Last updated on 2022-17-01 at 11:43